Safety and clinical efficacy of the secretome of stressed peripheral blood mononuclear cells in patients with diabetic foot ulcer—study protocol of the randomized, placebo-controlled, double-blind, multicenter, international phase II clinical trial MARSYAS II

被引：0
作者：
Alfred Gugerell
Ghazaleh Gouya-Lechner
Helmut Hofbauer
Maria Laggner
Franz Trautinger
Gabriele Almer
Anja Peterbauer-Scherb
Marcus Seibold
Wolfram Hoetzenecker
Christiane Dreschl
Michael Mildner
Hendrik Jan Ankersmit
机构：
[1] Medical University of Vienna,Division of Thoracic Surgery
[2] Aposcience AG,Clinical Department for Skin and Venereal Diseases
[3] Universitaetsklinikum St.Poelten,Department of Dermatology and Venerology
[4] Austrian Red Cross Blood Transfusion Service of Upper Austria,Department of Surgery
[5] Kepler University Hospital,Research Division of Biology and Pathobiology of the Skin, Department of Dermatology
[6] Krankenhaus der Elisabethinen Klagenfurt,undefined
[7] Medical University of Vienna,undefined
来源：
Trials | / 22卷
关键词：
Diabetic foot ulcer; Secretome-based therapy; Peripheral blood mononuclear cells; Skin; Inflammation; (Impaired) wound healing; Biological; Hydrogel; Clinical trial protocol; Randomized controlled trial;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Cyclosporine for moderate-to-severe alopecia areata: A double-blind, randomized, placebo-controlled clinical trial of efficacy and safety
    Lai, Vivien Wai Yun
    Chen, Gang
    Gin, Douglas
    Sinclair, Rodney
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (03) : 694 - 701
  • [42] Efficacy and safety of pentoxifylline combination therapy in major depressive disorder: a randomized, double-blind, placebo-controlled clinical trial
    Farajollahi-Moghadam, Mostafa
    Sanjari-Moghaddam, Hossein
    Hasemi, Maryam Ghazizadeh
    Sanatian, Zahra
    Talaei, Ali
    Akhondzadeh, Shahin
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2021, 36 (03) : 140 - 146
  • [43] Zopiclone versus placebo for short-term treatment of insomnia in patients with advanced cancer: study protocol for a double-blind, randomized, placebo-controlled, clinical multicenter trial
    Gunnhild Jakobsen
    Morten Engstrøm
    Ørnulf Paulsen
    Karin Sjue
    Sunil X. Raj
    Morten Thronæs
    Marianne Jensen Hjermstad
    Stein Kaasa
    Peter Fayers
    Pål Klepstad
    Trials, 19
  • [44] Zopiclone versus placebo for short-term treatment of insomnia in patients with advanced cancer: study protocol for a double-blind, randomized, placebo-controlled, clinical multicenter trial
    Jakobsen, Gunnhild
    Engstrom, Morten
    Paulsen, Ornulf
    Sjue, Karin
    Raj, Sunil X.
    Thronaes, Morten
    Hjermstad, Marianne Jensen
    Kaasa, Stein
    Fayers, Peter
    Klepstad, Pal
    TRIALS, 2018, 19
  • [45] Efficacy and Safety of Niaoduqing Particles for Delaying Moderate-to-severe Renal Dysfunction: A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Study
    Zheng, Ying
    Cai, Guang-Yan
    He, Li-Qun
    Lin, Hong-Li
    Cheng, Xiao-Hong
    Wang, Nian-Song
    Jian, Gui-Hua
    Liu, Xu-Sheng
    Liu, Yu-Ning
    Ni, Zhao-Hui
    Fang, Jing-Ai
    Ding, Han-Lu
    Guo, Wang
    He, Ya-Ni
    Wang, Li-Hua
    Wang, Ya-Ping
    Yang, Hong-Tao
    Ye, Zhi-Ming
    Yu, Ren-Huan
    Zhao, Li-Juan
    Zhou, Wen-Hua
    Li, Wen-Ge
    Mao, Hui-Juan
    Zhan, Yong-Li
    Hu, Zhao
    Yao, Chen
    Wei, Ri-Bao
    Chen, Xiang-Mei
    CHINESE MEDICAL JOURNAL, 2017, 130 (20) : 2402 - +
  • [46] A phase II, single-center, double-blind, randomized placebo-controlled trial to explore the efficacy and safety of intravenous melatonin in patients with COVID-19 admitted to the intensive care unit (MelCOVID study): a structured summary of a study protocol for a randomized controlled trial
    Rodriguez-Rubio, Miguel
    Figueira, Juan Carlos
    Acuna-Castroviejo, Dario
    Borobia, Alberto M.
    Escames, Germaine
    de la Oliva, Pedro
    TRIALS, 2020, 21 (01)
  • [47] Efficacy and Safety of Niaoduqing Particles for Delaying Moderate-to-severe Renal Dysfunction: A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Study
    Zheng Ying
    Cai Guang-Yan
    He Li-Qun
    Lin Hong-Li
    Cheng Xiao-Hong
    Wang Nian-Song
    Jian Gui-Hua
    Liu Xu-Sheng
    Liu Yu-Ning
    Ni Zhao-Hui
    Fang Jing-Ai
    Ding Han-Lu
    Guo Wang
    He Ya-Ni
    Wang Li-Hua
    Wang Ya-Ping
    Yang Hong-Tao
    Ye Zhi-Ming
    Yu Ren-Huan
    Zhao Li-Juan
    Zhou Wen-Hua
    Li Wen-Ge
    Mao Hui-Juan
    Zhan Yong-Li
    Hu Zhao
    Yao Chen
    Wei Ri-Bao
    Chen Xiang-Mei
    中华医学杂志英文版, 2017, 130 (20) : 2402 - 2409
  • [48] A phase II, single-center, double-blind, randomized placebo-controlled trial to explore the efficacy and safety of intravenous melatonin in patients with COVID-19 admitted to the intensive care unit (MelCOVID study): a structured summary of a study protocol for a randomized controlled trial
    Miguel Rodríguez-Rubio
    Juan Carlos Figueira
    Darío Acuña-Castroviejo
    Alberto M. Borobia
    Germaine Escames
    Pedro de la Oliva
    Trials, 21
  • [49] A randomized, double-blind, placebo-controlled, multicenter clinical trial for efficacy and safety of traditional Chinese medicine combined with antibiotics in the treatment of bacterial pneumonia in children
    Wei, Lina
    Guo, Yina
    Fei, Yutong
    Luo, Lin
    Wang, Caiwen
    Wang, Xuejiao
    Sun, Haihang
    Liu, Liang
    Han, Jing
    Ren, Xiaoting
    Yao, Bo
    Wang, Lei
    Wang, Yijie
    Sun, Liping
    MEDICINE, 2020, 99 (50) : E23217
  • [50] The effects of vitamin D supplementation on wound healing and metabolic status in patients with diabetic foot ulcer: A randomized, double-blind, placebo-controlled trial
    Razzaghi, Reza
    Pourbagheri, Hamideh
    Momen-Heravi, Mansooreh
    Bahmani, Fereshteh
    Shadi, Jafar
    Soleimani, Zahra
    Asemi, Zatollah
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2017, 31 (04) : 766 - 772
12345